Literature DB >> 2699586

A microfluorometric viability assay for isolated human and rat islets of Langerhans.

N J London1, H Contractor, S P Lake, G C Aucott, P R Bell, R F James.   

Abstract

A microfluorometric viability assay for isolated human and rat islets of Langerhans has been developed using the fluorochromes fluorescein diacetate and propidium iodide. Fluoroscein diacetate causes live cells to fluoresce green under blue light excitation (490 nm); propidium iodide causes dead cells to fluoresce red under green light excitation (545 nm). The fluorescence intensity from the live and dead cells within a single islet was selectively measured by photometry using 520 nm and 610 nm barrier filters with blue and green light excitation respectively. All measurements were corrected for background fluorescence. It was necessary to incubate single islets with the fluorochrome mixture for 105 min in order to achieve maximum fluorescence intensity. It was found that when 50 microliters of a fluorochrome mixture containing 0.67 mumol/l fluorescein diacetate and 4.0 mumol/l propidium iodide was incubated with a single islet and the fluorescence from live (blue light excitation) and dead (green light excitation) cells measured, then the proportion of dead cells within the islet was equal to the (propidium iodide fluorescence)--(0.04 x fluorescein fluorescence) divided by the sum of the (fluorescein fluorescence) and (propidium iodide fluorescence--(0.04 x fluorescein fluorescence]. The proportion of dead cells within single human or rat islets measured by microfluorometry was found to correlate highly significantly (r = 0.99, p less than 0.001) with the proportion of dead cells measured by dissociating the same islet into a single cell suspension and counting the actual proportion of dead cells. This assay therefore provides a rapid, accurate and objective measurement of the proportion of dead cells within isolated human and rat islets.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2699586

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  9 in total

1.  Limitations in the Use of Fluorescein Diacetate/Propidium Iodide (FDA/PI) and Cell Permeable Nucleic Acid Stains for Viability Measurements of Isolated Islets of Langerhans.

Authors:  Vinc Boyd; Olivia Maria Cholewa; Klearchos K Papas
Journal:  Curr Trends Biotechnol Pharm       Date:  2008-03

2.  Evaluation of viable β-cell mass is useful for selecting collagenase for human islet isolation: comparison of collagenase NB1 and liberase HI.

Authors:  R Misawa; C Ricordi; A Miki; S Barker; R D Molano; A Khan; S Miyagawa; L Inverardi; R Alejandro; A Pileggi; H Ichii
Journal:  Cell Transplant       Date:  2011-09-16       Impact factor: 4.064

3.  Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets.

Authors:  Barbara Ludwig; Christian G Ziegler; Andrew V Schally; Claudius Richter; Anja Steffen; Normund Jabs; Richard H Funk; Mathias D Brendel; Norman L Block; Monika Ehrhart-Bornstein; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

4.  Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.

Authors:  U Zumsteg; J I Reimers; F Pociot; L Mørch; S Helqvist; M Brendel; R Alejandro; T Mandrup-Poulsen; C A Dinarello; J Nerup
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

5.  Clinical studies of human islet transplantation.

Authors:  N J London
Journal:  Ann R Coll Surg Engl       Date:  1995-07       Impact factor: 1.891

Review 6.  Current status of islet cell transplantation.

Authors:  Hirohito Ichii; Camillo Ricordi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-12-26

7.  Impact of islet size on pancreatic islet transplantation and potential interventions to improve outcome.

Authors:  Daria Zorzi; Tammy Phan; Marco Sequi; Yong Lin; Daniel H Freeman; Luca Cicalese; Cristiana Rastellini
Journal:  Cell Transplant       Date:  2013-10-18       Impact factor: 4.064

8.  Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice.

Authors:  K K Papas; C K Colton; R A Nelson; P R Rozak; E S Avgoustiniatos; W E Scott; G M Wildey; A Pisania; G C Weir; B J Hering
Journal:  Am J Transplant       Date:  2007-01-04       Impact factor: 8.086

9.  APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model.

Authors:  Fang Xiao; Liang Ma; Min Zhao; Richard A Smith; Guocai Huang; Peter M Jones; Shanta Persaud; Attilio Pingitore; Anthony Dorling; Robert Lechler; Giovanna Lombardi
Journal:  Br J Pharmacol       Date:  2016-01-11       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.